221 related articles for article (PubMed ID: 29189975)
21. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
22. Development of Collaborative Drug Therapy Management and Clinical Pharmacy Services in an Outpatient Psychiatric Clinic.
Tewksbury A; Bozymski KM; Ruekert L; Lum C; Cunningham E; Covington F
J Pharm Pract; 2018 Jun; 31(3):272-278. PubMed ID: 28539104
[TBL] [Abstract][Full Text] [Related]
23. Trends in Polypharmacy in Japan: A Nationwide Retrospective Study.
Onoue H; Koyama T; Zamami Y; Hagiya H; Tatebe Y; Mikami N; Shinomiya K; Kitamura Y; Hinotsu S; Sendo T; Ouchi Y; Kano MR
J Am Geriatr Soc; 2018 Dec; 66(12):2267-2273. PubMed ID: 30291747
[TBL] [Abstract][Full Text] [Related]
24. Store and prescription characteristics associated with primary medication nonadherence.
Jackson TH; Bentley JP; McCaffrey DJ; Pace P; Holmes E; West-Strum D
J Manag Care Spec Pharm; 2014 Aug; 20(8):824-32. PubMed ID: 25062076
[TBL] [Abstract][Full Text] [Related]
25. Community pharmacy transition of care services and rural hospital readmissions: A case study.
Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Pharmacists' Willingness to Conduct Medication Use Reviews in Poland.
Merks P; Religioni U; Waszyk-Nowaczyk M; Kaźmierczak J; Białoszewski A; Blicharska E; Kowalczuk A; Neumann-Podczaska A
Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162889
[TBL] [Abstract][Full Text] [Related]
27. Performance of community pharmacists in providing clinical medication reviews.
Laaksonen R; Duggan C; Bates I
Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
[TBL] [Abstract][Full Text] [Related]
28. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.
Branham AR; Katz AJ; Moose JS; Ferreri SP; Farley JF; Marciniak MW
J Pharm Pract; 2013 Aug; 26(4):420-7. PubMed ID: 23178415
[TBL] [Abstract][Full Text] [Related]
30. Legislation on the Roles of the Pharmacist and Pharmacy in the Revision of the Pharmaceutical and Medical Device Act and the Pharmacists Act in Japan.
Takamura K; Tachibana K; Kihira T; Nakai K; Tsutsumi Y; Kondoh M
Ther Innov Regul Sci; 2021 Mar; 55(2):304-308. PubMed ID: 32918260
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
Christensen DB; Roth M; Trygstad T; Byrd J
J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
[TBL] [Abstract][Full Text] [Related]
32. Opinion comparison concerning future information technology in Finnish community pharmacies.
Westerling AM; Hynninen JT; Haikala VE; Airaksinen MS
Pharm World Sci; 2010 Dec; 32(6):787-94. PubMed ID: 20848207
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
[TBL] [Abstract][Full Text] [Related]
34. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems.
Modig S; Holmdahl L; Bondesson Å
Int J Clin Pharm; 2016 Feb; 38(1):41-5. PubMed ID: 26582483
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists' dispensing practices.
Gebregeorgise DT; Belay YM; Kälvemark Sporrong S
Int J Clin Pharm; 2018 Feb; 40(1):67-73. PubMed ID: 29134487
[TBL] [Abstract][Full Text] [Related]
36. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
Trapskin K; Johnson C; Cory P; Sorum S; Decker C
J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
[TBL] [Abstract][Full Text] [Related]
37. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
38. A structured patient identification model for medication therapy management services in a community pharmacy.
Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
[TBL] [Abstract][Full Text] [Related]
39. [Current Status of Community Pharmacies: Expectations as a Health Information Hub, the Enforcement of Revised Pharmaceutical and Medical Device Act, and a New Role as Stakeholders].
Saito M
Yakugaku Zasshi; 2016; 136(2):245-9. PubMed ID: 26831801
[TBL] [Abstract][Full Text] [Related]
40. Transition of care: A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine ward.
Neeman M; Dobrinas M; Maurer S; Tagan D; Sautebin A; Blanc AL; Widmer N
Eur J Intern Med; 2017 Mar; 38():30-37. PubMed ID: 27890453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
